These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19473593)

  • 1. Impact of insulin sensitivity treatment with pioglitazone on endothelial function in non-diabetic patients with arterial hypertension.
    Schneider F; Vossler S; Franke S; Bär F; Konrad T
    Int J Clin Pharmacol Ther; 2009 May; 47(5):311-20. PubMed ID: 19473593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients.
    Konrad T; Franke S; Schneider F; Bär F; Vetter G; Winkler K
    J Hum Hypertens; 2011 Jan; 25(1):18-24. PubMed ID: 20237501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension.
    Horio T; Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Yoshimasa Y; Kawano Y
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1626-30. PubMed ID: 16364837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
    Anan F; Masaki T; Fukunaga N; Teshima Y; Iwao T; Kaneda K; Umeno Y; Okada K; Wakasugi K; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
    Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone reduces blood pressure in non-dipping diabetic patients.
    Negro R; Dazzi D; Hassan H; Pezzarossa A
    Minerva Endocrinol; 2004 Mar; 29(1):11-7. PubMed ID: 15258553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study.
    Füllert S; Schneider F; Haak E; Rau H; Badenhoop K; Lübben G; Usadel KH; Konrad T
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5503-6. PubMed ID: 12466345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.
    Martens FM; Visseren FL; de Koning EJ; Rabelink TJ
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):773-8. PubMed ID: 16306801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone ameliorates endothelial dysfunction in those with impaired glucose regulation among the first-degree relatives of type 2 diabetes mellitus patients.
    Yu X; Chen P; Wang H; Zhu T
    Med Princ Pract; 2013; 22(2):156-60. PubMed ID: 22964975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects.
    Magen E; Viskoper JR; Mishal J; Priluk R; London D; Yosefy C
    J Hum Hypertens; 2005 Sep; 19(9):667-73. PubMed ID: 16034448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase.
    Sarafidis PA; Lasaridis AN; Nilsson PM; Pagkalos EM; Hitoglou-Makedou AD; Pliakos CI; Kazakos KA; Yovos JG; Zebekakis PE; Tziolas IM; Tourkantonis AN
    J Hypertens; 2004 Sep; 22(9):1769-77. PubMed ID: 15311106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes.
    Sourij H; Zweiker R; Wascher TC
    Diabetes Care; 2006 May; 29(5):1039-45. PubMed ID: 16644634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives.
    Grassi D; Necozione S; Lippi C; Croce G; Valeri L; Pasqualetti P; Desideri G; Blumberg JB; Ferri C
    Hypertension; 2005 Aug; 46(2):398-405. PubMed ID: 16027246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
    Raji A; Gerhard-Herman MD; Williams JS; O'connor ME; Simonson DC
    Diabet Med; 2006 May; 23(5):537-43. PubMed ID: 16681563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.
    Smith JC; Evans LM; Wilkinson I; Goodfellow J; Cockcroft JR; Scanlon MF; Davies JS
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):493-501. PubMed ID: 11966742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone improves endothelial dysfunction in patients with insulin resistance.
    Watanabe Y; Sunayama S; Shimada K; Sawano M; Hoshi S; Iwama Y; Mokuno H; Daida H; Yamaguchi H
    J Atheroscler Thromb; 2000; 7(3):159-63. PubMed ID: 11480457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA
    Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversing vascular dysfunction in rheumatoid arthritis: improved augmentation index but not endothelial function with peroxisome proliferator-activated receptor γ agonist therapy.
    Ormseth MJ; Oeser AM; Cunningham A; Bian A; Shintani A; Solus J; Tanner SB; Stein CM
    Arthritis Rheumatol; 2014 Sep; 66(9):2331-8. PubMed ID: 24782291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between insulin resistance and endothelial dysfunction in type 2 diabetes and the effects of pioglitazone.
    Suzuki M; Takamisawa I; Yoshimasa Y; Harano Y
    Diabetes Res Clin Pract; 2007 Apr; 76(1):12-7. PubMed ID: 17007957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.
    Garg R; Kneen L; Williams GH; Adler GK
    Diabetes Obes Metab; 2014 Mar; 16(3):268-72. PubMed ID: 24125483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.